126 related articles for article (PubMed ID: 15258678)
21. Transdermal contraceptive patch--a new birth control option.
Banerjee S
Issues Emerg Health Technol; 2001 Nov; (26):1-4. PubMed ID: 11902225
[No Abstract] [Full Text] [Related]
22. [Transdermal contraception--a new beginning].
Sigridov I; Dikov I; Ivanov S
Akush Ginekol (Sofiia); 2004; 43 Suppl 1():19-27. PubMed ID: 15323313
[No Abstract] [Full Text] [Related]
23. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data.
Zieman M; Guillebaud J; Weisberg E; Shangold GA; Fisher AC; Creasy GW
Fertil Steril; 2002 Feb; 77(2 Suppl 2):S13-8. PubMed ID: 11849631
[TBL] [Abstract][Full Text] [Related]
24. The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy.
Archer DF; Cullins V; Creasy GW; Fisher AC
Contraception; 2004 Mar; 69(3):189-95. PubMed ID: 14969665
[TBL] [Abstract][Full Text] [Related]
25. Progress in contraception: new technology.
Linn ES
Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551
[TBL] [Abstract][Full Text] [Related]
26. Performance of contraceptive patch compared with oral contraceptive pill in a high-risk population.
Bakhru A; Stanwood N
Obstet Gynecol; 2006 Aug; 108(2):378-86. PubMed ID: 16880309
[TBL] [Abstract][Full Text] [Related]
27. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Henzl MR; Loomba PK
J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
[TBL] [Abstract][Full Text] [Related]
28. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic overview of Ortho Evra/Evra.
Abrams LS; Skee D; Natarajan J; Wong FA
Fertil Steril; 2002 Feb; 77(2 Suppl 2):S3-12. PubMed ID: 11849630
[TBL] [Abstract][Full Text] [Related]
30. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
Creasy GW; Fisher AC; Hall N; Shangold GA
J Reprod Med; 2003 Mar; 48(3):179-86. PubMed ID: 12698776
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of a transdermal contraceptive system.
Smallwood GH; Meador ML; Lenihan JP; Shangold GA; Fisher AC; Creasy GW;
Obstet Gynecol; 2001 Nov; 98(5 Pt 1):799-805. PubMed ID: 11704172
[TBL] [Abstract][Full Text] [Related]
32. Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
White T; Jain JK; Stanczyk FZ
Am J Obstet Gynecol; 2005 Jun; 192(6):2055-9. PubMed ID: 15970897
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise.
Abrams LS; Skee DM; Natarajan J; Wong FA; Leese PT; Creasy GW; Shangold MM
J Clin Pharmacol; 2001 Dec; 41(12):1301-9. PubMed ID: 11762557
[TBL] [Abstract][Full Text] [Related]
34. The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
Wooltorton E
CMAJ; 2006 Jan; 174(2):164-5. PubMed ID: 16368722
[No Abstract] [Full Text] [Related]
35. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites.
Abrams LS; Skee DM; Natarajan J; Wong FA; Anderson GD
Br J Clin Pharmacol; 2002 Feb; 53(2):141-6. PubMed ID: 11851637
[TBL] [Abstract][Full Text] [Related]
36. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Levine JP
J Fam Pract; 2004 Nov; 53(11):904-13. PubMed ID: 15527729
[No Abstract] [Full Text] [Related]
37. Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches.
Abrams LS; Skee DM; Wong FA; Anderson NJ; Leese PT
J Clin Pharmacol; 2001 Nov; 41(11):1232-7. PubMed ID: 11697756
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
Devineni D; Skee D; Vaccaro N; Massarella J; Janssens L; LaGuardia KD; Leung AT
J Clin Pharmacol; 2007 Apr; 47(4):497-509. PubMed ID: 17389559
[TBL] [Abstract][Full Text] [Related]
39. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
Stewart FH; Kaunitz AM; Laguardia KD; Karvois DL; Fisher AC; Friedman AJ
Obstet Gynecol; 2005 Jun; 105(6):1389-96. PubMed ID: 15932834
[TBL] [Abstract][Full Text] [Related]
40. Women prefer Ortho Evra patch.
AWHONN Lifelines; 2003; 7(5):460. PubMed ID: 14628730
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
